Journal article
Impact of Desloratadine on Symptoms and Quality of Life in Subjects with Chronic Idiopathic Urticaria: A Multicenter, Practice‐based Study
Abstract
BACKGROUND: Controlled trials have demonstrated the efficacy of antihistamines in the treatment of chronic idiopathic urticaria. Second-generation antihistamines are recommended as first-line therapy for chronic idiopathic urticaria. The purpose of this study was to determine the effect of desloratadine, a newer, nonsedating, second-generation antihistamine, on symptoms of chronic idiopathic urticaria, disease severity, and quality of life …
Authors
Kim H; Lynde C
Journal
Archives of Drug Information, Vol. 1, No. 2, pp. 63–69
Publisher
Wiley
Publication Date
September 2008
DOI
10.1111/j.1753-5174.2008.00010.x
ISSN
1753-5174